Federal Funding Program Comparisons

Program comparisons and fit guides

• DARPA Office Fit Guide: Which Office Should You Target?: Map your technology to the right DARPA office—BTO, DSO, I2O, MTO, or TTO—before investing in a BAA response.
• NIH Institute Fit Guide: NIAID, NCI, NHLBI, NINDS, or NIGMS?: Choose the right NIH institute based on disease area, study design, and translational intent before proposal investment.
• BARDA EZ-BAA vs DRIV: Program Fit Comparison: Compare BARDA EZ-BAA and DRIV pathways for health security innovators evaluating speed, scope, and mission alignment.
• DOE Section 1703 vs 1706: Readiness Comparison: Evaluate DOE 1703 and 1706 pathways based on project type, financing structure, and deployment readiness.
• DOE Loan vs ARPA-E: Which Path Fits Your Program?: Compare DOE loan pathways and ARPA-E opportunities by capital intensity, technical risk, and readiness requirements.
• DARPA BAA vs DIU Pathway: How to Choose: Understand when to pursue DARPA BAA responses versus DIU commercial transition pathways for defense funding.
• BARDA Full Solicitation vs EZ-BAA: Speed vs Scope: Decide between BARDA full solicitations and EZ-BAA based on maturity, scope breadth, and response timeline.
• NIAID vs BARDA: Research vs Countermeasure Development: Compare NIAID and BARDA pathways for infectious disease and health security innovators at different maturity stages.
• DOE SBIR/STTR vs ARPA-E: Seed vs Transformational Programs: Choose between DOE SBIR/STTR and ARPA-E based on company stage, technical risk profile, and award scale.
• DTRA vs DIU: Threat Reduction vs Commercial Transition: Compare DTRA and DIU pathways for defense technology teams evaluating mission fit and submission format.
• OCED vs DOE Loan Programs: Deployment Incentives vs Project Finance: Understand when OCED funding mechanisms fit versus DOE LPO loan pathways for energy deployment programs.
• ASPR IBx vs BARDA EZ-BAA: Rapid Health Security Pathways: Compare ASPR IBx and BARDA EZ-BAA for innovators pursuing fast-turn health security and medical countermeasure opportunities.
• CISA vs DARPA I2O: Which Cyber Pathway Fits Your Team?: Cyber and critical-infrastructure teams often conflate CISA operational grants with DARPA I2O research funding—choose based on mission fit and product maturity.
• CHIPS Act vs DARPA MTO: Manufacturing Incentives or Microsystems R&D?: Semiconductor teams often debate CHIPS manufacturing incentives against DARPA MTO BAAs—match pathway to facility scale-up vs advanced microsystems research.
• ARPA-H vs BARDA: Health Innovation Pathway Comparison: Compare ARPA-H and BARDA for health security and medtech teams deciding between transformational health R&D and countermeasure development pathways.